Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The incidence of pleurisy is regularly associated with underlying respiratory conditions, which includes pneumonia, tuberculosis, or viral infections. The prevalence of these respiratory situations contributes immediately to the demand for pleurisy prognosis and remedy, shaping the market. Ongoing advancements in imaging strategies, which include chest X-rays, CT scans, and ultrasound, play a critical function in shaping the pleurisy market. Improved diagnostic competencies contribute to greater correct and timely identification of pleurisy, influencing remedy strategies. Autoimmune disorders, which include lupus or rheumatoid arthritis, are related to pleurisy. The occurrence of autoimmune situations affects the market as patients with those disorders may additionally require specialized diagnostic and healing approaches for pleurisy. Pleurisy may be a symptom of certain cancers, in particular, the ones affecting the lungs or pleura.
Exposures to environmental pollution, asbestos, or occupational dangers can contribute to pleurisy. Changes in environmental conditions and occupational protection practices impact the market as they have an impact on the risk elements associated with pleurisy. The kingdom of healthcare infrastructure and entry to to diagnostic services affect the pleurisy market. Regions with well-hooked-up healthcare systems and substantial access to diagnostic technology can also revel in unique market dynamics as compared to regions with limited resources. Advances in therapeutics, inclusive of anti-inflammatory medicinal drugs, impact the pleurisy market. Treatment options that deal with the underlying reasons for pleurisy make a contribution to progress affected person results and impact the demand for particular medicines.
Patient attention to respiratory signs and symptoms and the significance of early detection impacts the pleurisy market. Timely recognition of symptoms and looking for scientific attention for pleurisy-associated conditions contribute to the demand for diagnostic offerings. Stringent regulatory compliance and standards in the healthcare enterprise affect the pleurisy market. Adherence to regulatory requirements ensures the protection and efficacy of diagnostic and therapeutic interventions for pleurisy, shaping market dynamics. Economic conditions and healthcare spending impact the pleurisy market. Affordability and admission to to healthcare services, which include diagnostic techniques and remedies for pleurisy, are stimulated by way of financial factors and healthcare price range allocations.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Growth Rate | Â Â 6.8% |
Pleurisy Market Highlights:
Pleurisy Market Overview
Pleurisy Market Size was valued at USD 1.73 Billion in 2023. The Pleurisy industry is projected to grow from USD 1.83 Billion in 2024 to USD 3.23 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.94% during the forecast period (2024 - 2032).
Pleurisy is the inflammation of the membrane known as pleura that surrounds the lungs inside the chest cavity. People suffering with pleurisy can experience chest pain while breathing. This disease is characterized by symptoms such as shortness of breath, cough, fever, and weight loss. Pneumonia, pulmonary embolism, autoimmune disorder, lung cancer, heart surgery, pancreatitis, chest trauma, and asbestosis are the diseases which cause pleurisy, thus, rising in population affected with these disease are the leading factor for the growth of global pleurisy market. According to a report published by the World Cancer Research Fund International, in 2015, about 58% of lung cancer cases occurred in the developing countries. In a similar report by Centers for Disease Control and Prevention (CDC), in 2017, lung cancer is the leading cause of cancer death and the second most common cancer among both men and women in the United States.
There are various causes responsible for this condition, such as rising aging population, unhealthy diet, low physical activities, etc. According to a research, smoking increases the possibility of lung cancer; more than 60% of the global population smokes, this has increased the risk of lung cancer and contributed to the growth of the market. Moreover, advancing technology in medical devices is adding fuel to the growth of the market. Furthermore, increasing government support for the developing countries also drives the market growth. However, availability of expensive treatment and poor reimbursement policies in the developing regions of the world are some of the factors, which may hamper the market growth during the forecast period.
Pleurisy is the inflammation of the membrane known as pleura that surrounds the lungs inside the chest cavity. People suffering with pleurisy can experience chest pain while breathing. This disease is characterized by symptoms such as shortness of breath, cough, fever, and weight loss. Pneumonia, pulmonary embolism, autoimmune disorder, lung cancer, heart surgery, pancreatitis, chest trauma, and asbestosis are the diseases which cause pleurisy, thus, rising in population affected with these disease are the leading factor for the growth of global pleurisy market. According to a report published by the World Cancer Research Fund International, in 2015, about 58% of lung cancer cases occurred in the developing countries. In a similar report by Centers for Disease Control and Prevention (CDC), in 2017, lung cancer is the leading cause of cancer death and the second most common cancer among both men and women in the United States.
There are various causes responsible for this condition, such as rising aging population, unhealthy diet, low physical activities, etc. According to a research, smoking increases the possibility of lung cancer; more than 60% of the global population smokes, this has increased the risk of lung cancer and contributed to the growth of the market. Moreover, advancing technology in medical devices is adding fuel to the growth of the market. Furthermore, increasing government support for the developing countries also drives the market growth. However, availability of expensive treatment and poor reimbursement policies in the developing regions of the world are some of the factors, which may hamper the market growth during the forecast period.
Pleurisy Market Segment Insights
The pleurisy global market is segmented on the basis of diagnosis devices, treatment, and by end user. On the basis of the diagnosis devices, it is segmented into thoracentesis, video-assisted thoracic surgery, imaging devices, blood test, and others. Furthermore, imaging devices are segmented as computed tomography, magnetic resonance imaging, ultrasound, and others.
On the basis of the treatment, it is segmented into antibiotics, antifungals, blood thinners, nonsteroidal anti-inflammatory drugs, and others. On the basis of end user, it is segmented into hospital, clinics, diagnostics laboratories, and others.
Pleurisy Market Regional Analysis
The Americas dominate the global pleurisy market owing to the rising prevalence of disease such as autoimmune disorders, lung cancer, heart surgery, pancreatitis, chest trauma. Furthermore increasing government support for research & development and high healthcare spending have fuelled the growth of the market in this region. According to a report published by the Centers for Disease Control and Prevention (CDC), in 2014, around 215,951 people in the United States were diagnosed with lung cancer, including 113,326 men and 102,625 women. Also around 155,526 people in the United States died from lung cancer, including 84,859 men and 70,667 women.
Europe holds the second position in the global pleurisy market owing to the government support for research & development and availability of funds for research. Moreover, people of this region are more healthcare awareness. This is expected to continue to drive the European market over the forecasted period.
Asia Pacific is the fastest growing pleurisy market owing to the high presence of patient with chronic disease. Although rapidly developing healthcare technology, increasing demand for new treatment methods in countries like India and China is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare provide the opportunity for the market players to fill the gap between demand and supply and maximize the profits.
Europe holds the second position in the global pleurisy market owing to the government support for research & development and availability of funds for research. Moreover, people of this region are more healthcare awareness. This is expected to continue to drive the European market over the forecasted period.
Asia Pacific is the fastest growing pleurisy market owing to the high presence of patient with chronic disease. Although rapidly developing healthcare technology, increasing demand for new treatment methods in countries like India and China is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare provide the opportunity for the market players to fill the gap between demand and supply and maximize the profits.
On the other hand, in the Middle East and Africa, hold the least market due to low research and development activities and poor healthcare infrastructure.
Pleurisy Market Key Players
Some of the key players in this market are:
- Scanlan International, Inc. (U.S.)
- Sontec Instruments (U.S.)
- Pilling Surgical Inc. (U.S.)
- Integra LifeSciences Corporation (U.S.)
- Olympus Corporation (Japan)
- Delacroix-Chevalier (France)
- Myra & Co. (India)
- Wexler Surgical (Texas)
Research Methodology 
Sources: Annual reports, Press release, White paper, and Company presentation
Intended Audience
- Medical Devices Manufacturers
- Government Research Laboratories
- Research and Development (R&D) Companies
- Government and Independent Regulatory Authorities
- Market Research and Consulting Service Providers
- Medical Research Laboratories
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
